Lexicon Pharmaceuticals, Inc. (LXRX) has a market capitalization of $741.44M and trades at $1.75. The 52-week range is 0.36-1.83.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -12.5, Earnings Per Share (EPS) of $-0.14, annual revenue of $49.8M.
The stock has a beta of 0.95, operates in the Healthcare sector.
